Johnson & Johnson (NYSE:JNJ – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 12,190,000 shares, an increase of 12.1% from the August 15th total of 10,870,000 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 6,780,000 shares, the days-to-cover ratio is presently 1.8 days.
Johnson & Johnson Trading Down 0.8 %
Shares of JNJ opened at $164.97 on Wednesday. The firm’s 50 day simple moving average is $168.71 and its 200 day simple moving average is $174.30. The company has a market capitalization of $433.74 billion, a P/E ratio of 24.01, a P/E/G ratio of 2.97 and a beta of 0.61. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.42 and a quick ratio of 1.17. Johnson & Johnson has a 1-year low of $155.72 and a 1-year high of $186.69.
Johnson & Johnson (NYSE:JNJ – Get Rating) last announced its earnings results on Tuesday, July 19th. The company reported $2.59 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.02. The business had revenue of $24.02 billion for the quarter, compared to the consensus estimate of $23.85 billion. Johnson & Johnson had a net margin of 19.21% and a return on equity of 36.14%. Johnson & Johnson’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm posted $2.48 earnings per share. Sell-side analysts forecast that Johnson & Johnson will post 10.7 earnings per share for the current fiscal year.
Johnson & Johnson Dividend Announcement
Johnson & Johnson announced that its Board of Directors has authorized a share repurchase plan on Wednesday, September 14th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 1.2% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
Analyst Ratings Changes
Several equities research analysts have commented on JNJ shares. Citigroup dropped their price objective on shares of Johnson & Johnson from $205.00 to $201.00 in a report on Wednesday, July 20th. Wells Fargo & Company upped their price objective on shares of Johnson & Johnson from $190.00 to $195.00 and gave the company an “overweight” rating in a report on Wednesday, July 13th. Daiwa Capital Markets started coverage on shares of Johnson & Johnson in a report on Wednesday, June 22nd. They set an “outperform” rating on the stock. SVB Leerink decreased their price target on Johnson & Johnson from $200.00 to $194.00 in a research report on Wednesday, July 20th. Finally, UBS Group decreased their price target on Johnson & Johnson from $185.00 to $180.00 in a research report on Thursday, July 21st. Four investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $189.78.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. Magnolia Capital Management Ltd. raised its stake in shares of Johnson & Johnson by 0.5% during the first quarter. Magnolia Capital Management Ltd. now owns 11,162 shares of the company’s stock worth $1,978,000 after acquiring an additional 55 shares in the last quarter. Howard Financial Services LTD. raised its stake in shares of Johnson & Johnson by 2.1% during the first quarter. Howard Financial Services LTD. now owns 2,757 shares of the company’s stock worth $489,000 after acquiring an additional 57 shares in the last quarter. American Financial Advisors LLC raised its stake in shares of Johnson & Johnson by 2.1% during the first quarter. American Financial Advisors LLC now owns 2,715 shares of the company’s stock worth $481,000 after acquiring an additional 57 shares in the last quarter. Taylor & Morgan Wealth Management LLC raised its stake in shares of Johnson & Johnson by 1.6% during the second quarter. Taylor & Morgan Wealth Management LLC now owns 3,580 shares of the company’s stock worth $635,000 after acquiring an additional 57 shares in the last quarter. Finally, Kwmg LLC grew its holdings in shares of Johnson & Johnson by 2.6% in the first quarter. Kwmg LLC now owns 2,354 shares of the company’s stock worth $417,000 after purchasing an additional 59 shares during the last quarter. 68.59% of the stock is owned by hedge funds and other institutional investors.
Johnson & Johnson Company Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.